390 related articles for article (PubMed ID: 15283052)
41. [Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Cao Y; Xiang Y; Feng FZ; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):928-30. PubMed ID: 19134333
[TBL] [Abstract][Full Text] [Related]
42. Placental site trophoblastic tumor: report of four cases and review of literature.
Piura B; Rabinovich A; Meirovitz M; Shaco-Levy R
Int J Gynecol Cancer; 2007; 17(1):258-62. PubMed ID: 17291263
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
[TBL] [Abstract][Full Text] [Related]
44. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
45. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
Cole LA; Khanlian SA; Muller CY
J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
[TBL] [Abstract][Full Text] [Related]
46. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
47. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.
Xue WC; Guan XY; Ngan HY; Shen DH; Khoo US; Cheung AN
Cancer; 2002 Apr; 94(8):2288-94. PubMed ID: 12001129
[TBL] [Abstract][Full Text] [Related]
48. Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center.
Finkler NJ; Berkowitz RS; Driscoll SG; Goldstein DP; Bernstein MR
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):854-7. PubMed ID: 2835717
[TBL] [Abstract][Full Text] [Related]
49. Inappropriate management of women with persistent low hCG results.
Cole LA; Khanlian SA
J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathologic study of tumors of intermediate trophoblasts].
Li BZ; Zhu L; Duan W
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):722-6. PubMed ID: 17374255
[TBL] [Abstract][Full Text] [Related]
51. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
52. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
[TBL] [Abstract][Full Text] [Related]
53. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
54. Placental site trophoblastic tumor: report of a tertiary center experience.
Kuru O; Cetin C; Iyibozkurt C; Yavuz E
Eur J Gynaecol Oncol; 2015; 36(6):708-10. PubMed ID: 26775357
[TBL] [Abstract][Full Text] [Related]
55. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
56. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases.
Nagai Y; Kamoi S; Matsuoka T; Hata A; Jobo T; Ogasawara T; Aoki Y; Ohira S; Okamoto T; Nakamoto T; Kanda K; Matsui H
Gynecol Oncol; 2007 Sep; 106(3):446-52. PubMed ID: 17544490
[TBL] [Abstract][Full Text] [Related]
57. Pregnancy with primary tubal placental site trophoblastic tumor--A case report and literature review.
Su YN; Cheng WF; Chen CA; Lin TY; Hsieh FJ; Cheng SP; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):322-5. PubMed ID: 10329055
[TBL] [Abstract][Full Text] [Related]
58. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
59. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
60. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
